| Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the … P Deedwania, PH Stone, CN Bairey Merz, J Cosin-Aguilar, N Koylan, ... Circulation 115 (6), 700-707, 2007 | 327 | 2007 |
| Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension S Julius, P Palatini, SE Kjeldsen, A Zanchetti, MA Weber, GT McInnes, ... The American journal of cardiology 109 (5), 685-692, 2012 | 249 | 2012 |
| The valsartan antihypertensive long-term use evaluation (VALUE) trial: outcomes in patients receiving monotherapy S Julius, MA Weber, SE Kjeldsen, GT McInnes, A Zanchetti, HR Brunner, ... Hypertension 48 (3), 385-391, 2006 | 201 | 2006 |
| Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a … V Gyberg, D De Bacquer, K Kotseva, G De Backer, O Schnell, J Sundvall, ... European heart journal 36 (19), 1171-1177, 2015 | 124 | 2015 |
| Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension H Oflaz, C Cuhadaroglu, B Pamukcu, M Meric, T Ece, E Kasikcioglu, ... Respiration 73 (6), 751-756, 2006 | 76 | 2006 |
| The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation B Pamukcu, H Oflaz, RD Acar, S Umman, N Koylan, B Umman, Y Nisanci Journal of thrombosis and thrombolysis 20, 17-22, 2005 | 62 | 2005 |
| Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease B Pamukcu, H Oflaz, I Onur, A Oncul, B Umman, N Koylan, Z Bugra, ... Blood coagulation & fibrinolysis 18 (5), 461-465, 2007 | 53 | 2007 |
| Left ventricular geometric patterns and QT dispersion in untreated essential hypertension Z Buğra, N Koylan, A Vural, F Erzengin, B Umman, E Yãlmaz, M Meriç, ... American journal of hypertension 11 (10), 1164-1170, 1998 | 45 | 1998 |
| Importance of serum anticardiolipin antibody levels in coronary heart disease. E Yilmaz, K Adalet, G Yilmaz, S Badur, F Erzengin, N Koylan, ... Clinical cardiology 17 (3), 117-121, 1994 | 38 | 1994 |
| Effects of amlodipine and fosinopril on heart rate variability and left ventricular mass in mild‐to‐moderate essential hypertension AK Bilge, D Atilgan, T Tükek, M Özcan, B Özben, N Koylan, M Meric International journal of clinical practice 59 (3), 306-310, 2005 | 33 | 2005 |
| Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS) N Koylan, AK Bilge, K Adalet, F Mercanoglu, K Buyukozturk, TTS Group Acta cardiologica 59 (6), 644-650, 2004 | 32 | 2004 |
| Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the … G Kabakci, N Koylan, B Ilerigelen, O Kozan, K Buyukozturk Integrated blood pressure control, 5-13, 2008 | 25 | 2008 |
| Effect of irbesartan monotherapy compared with ACE inhibitors and calcium‐channel blockers on patient compliance in essential hypertension patients: A multicenter, open‐labeled … N Koylan, E Acarturk, A Canberk, N Caglar, S Caglar, S Erdine, S Guneri, ... Blood pressure 14 (sup1), 23-31, 2005 | 20 | 2005 |
| EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey L Tokgözoğlu, M Kayıkçıoğlu, S Altay, S Aydoğdu, C Barçın, C Bostan, ... Archives of the Turkish Society of Cardiology 45 (2), 134-144, 2017 | 19 | 2017 |
| EUROASPIRE-IV: Avrupa Kardiyoloji Derneği’nin koroner arter hastalarında yaşam tarzı, risk faktörleri ve tedavi yaklaşımı üzerine çalışması: Türkiye verileri L Tokgözoğlu, M Kayıkçıoğlu, S Altay, S Aydoğdu, C Barçın, C Bostan, ... Turk Kardiyol Dern Ars 45 (2), 134-144, 2017 | 18 | 2017 |
| Tachycardia predicts cardiovascular events in the VALUE trial S Julius, P Palatini, S Kjeldsen, A Zanchetti, MA Weber, GT McInnes, ... Am J Cardiol 109, 685-692, 2012 | 18 | 2012 |
| The impact of plasma high‐sensitivity C‐reactive protein levels on cardiovascular risk stratification of hypertensive patients: results of the ICEBERG study O Kozan, K Buyukozturk, B Ilerigelen, G Kabakci, N Koylan, ... The Journal of Clinical Hypertension 9 (7), 500-505, 2007 | 18 | 2007 |
| Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction A Onat, I Soydan, L Tokgözoǧlu, V Sansoy, N Koylan, N Domaniç, D Ural Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for …, 2003 | 18 | 2003 |
| Türk erişkinlerinde kalp sağlığının dünü ve bugünü A Onat, GŞ Avcı, İ Soydan, N Koylan, U Sansoy, L Tokgözoğlu Karakter Color Matbaası, Istanbul, 1996 | 18 | 1996 |
| The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients Ö Kozan, EE Özcan, O Sancaktar, G Kabakci, AH Sözcüer, A Kerpeten, ... Turk Kardiyoloji Dernegi Arsivi, 2011 | 17 | 2011 |
